Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters (DROMDP)

February 13, 2020 updated by: Alberto Leardini, DPhil, Istituto Ortopedico Rizzoli

Dynamic Range of Motion (ROM) Assessment Using Gait Analysis and Three-dimensional Fluoroscopy in Patients Treated by Total Hip Arthroplasty (THA) With Different Head Diameters

Pain and reduced function are the most common symptoms of coxarthritis. Pain relief and normal range of motion (ROM) restoration are the objectives of a Total Hip Arthroplasty (THA) procedure. It is recognized that increased head-neck ratio results in increased ROM due to the fact that prosthetic impingement between neck and acetabular liner occurs with wider arcs of motion. This head-neck ratio has been investigated extensively only in vitro (on cadavers or sawbones) or using mathematical modeling in computer simulations. These studies are limited by the lack of soft tissues and muscle activations in the models. This study will clinically assess the effect of prosthetic head diameter on patient capability of performing movements which require extreme arcs of motion of the hip joint. Therefore, the research questions are:

  • What role do soft tissues play in limiting ROM?
  • Can prosthetic impingement really occur in a well positioned THA?
  • Can a bigger head diameter alone reduce the risk of impingement?

Study Overview

Detailed Description

This will be a prospective comparative randomized double-blind Study (both patient and the clinical engineer performing the gait analysis will be blind with respect to the prosthetic head diameter implanted). Patient recruitment will last 12 months and the Study will have a follow-up period of 12 months. A total number of 45 patients will be recruited. Patients will be randomly allocated into three groups: the first group will undergo THA with a 28mm diameter head (Pinnacle Acetabular System, with a ceramic on ceramic - CoC - bearing), in the second group THA will be performed using a 36 mm diameter head (DeltaMotion), finally patients in the third group will undergo THA with a 40 mm diameter head (DeltaMotion). Patients will be operated by three surgeons of the same hospital according to the same surgical procedure and using the same direct lateral approach. All patients will receive a Corail stem and will follow the same rehabilitation program.

  • Primary endpoint: Gait analysis and fluoroscopy will provide quantitative information of prosthesis in vivo performance, e.g. what is the arc (degrees) of active or passive motion when prosthetic impingement occurs?
  • Secondary endpoint(s): these analyses will also allow to: 1) assess ROM of the operated hip versus contralateral non operated hip and the effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature; 2) set reproducible criteria for in vivo fluoroscopic analysis of ROM in THA patients.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BO
      • Bologna, BO, Italy, 40136
        • Istituto Ortopedico Rizzoli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with unilateral primary or secondary hip arthrosis indicated for THA;
  • Men and female, age between 35 and 55 years old;
  • BMI smaller than 30;
  • Patients able to understand the protocol and to sign the informed consent.

Exclusion Criteria:

  • Child-bearing female;
  • Patients with also controlateral hip arthritis;
  • Neurological patients, because of possible alteration of neuro-muscular control of the replaced hip;
  • Patients treated with joint replacement at any other lower limb articulation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: THA28
THA Corail PinnacleCoC28
Uncemented THA with Corail stem and Pinnacle acetabular cup with CoC 28 mm head
Active Comparator: THA36
THA Corail DeltaMotion36
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 36 mm head
Active Comparator: THA40
THA Corail DeltaMotion40
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 40 mm head

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants and Hip Joint Positions with the Occurrence of Implant Impingement
Time Frame: 12 months
Three-dimension videofluoroscopy is used to calculate prosthesis component relative pose, and to estimate minimum distance at the areas of risk of impingement
12 months
Number of Participants with Functional Deficits at the Hip Joint as Measured by Gait Analysis
Time Frame: 12 months
Three-dimension kinematics and kinetics of the trunk, pelvis and lower limb joints is used during level walking and other motor tasks, as well as for the single exercises of hip joint extreme motion analyzed in videofluoroscopy, to assess thoroughly those patients with and without impingement.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion of the operated hip versus contralateral non-operated hip
Time Frame: 12 months
Standard clinical range of motion at the two hips
12 months
Correlations between prosthetic head diameter and hip functional scores
Time Frame: 12 months
The effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature
12 months
Standard Clinical Hip Scores
Time Frame: pre-op, and 12 months
Outcomes: Harris Hip Score, Oxford Hip Score, WOMAC, Forgotten Joint score and UCLA activity score will be assessed and recorded pre-operatively and post-operatively at one year after surgery.
pre-op, and 12 months
X-ray measurements
Time Frame: 12 months
Radiographic assessment will also be performed at one year after surgery to assess implant position and osteointegration
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Sandro Giannini, MD, Prof, Istituto Ortopedico Rizzoli

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

December 21, 2017

Study Registration Dates

First Submitted

January 22, 2014

First Submitted That Met QC Criteria

January 24, 2014

First Posted (Estimate)

January 28, 2014

Study Record Updates

Last Update Posted (Actual)

February 17, 2020

Last Update Submitted That Met QC Criteria

February 13, 2020

Last Verified

February 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on THA Corail PinnacleCoC28

3
Subscribe